arthritis Archives -

Good news for Ironwood, which forecast annual sales of up to $300m, despite black box kidney failure warning.

FDA approves Ironwood’s gout combination drug

https://pharmaphorum.com/news/fda-approves-ironwoods-gout-combination-drug/

Earlier decision to reject drug reversed.

Otezla gains NICE approval for psoriatic arthritis

https://pharmaphorum.com/news/otezla-gains-nice-approval-psoriatic-arthritis/

Otezla cheap and convenient, but less effective than rivals, says NICE.

NICE says Otezla’s bargain price offsets lower efficacy

https://pharmaphorum.com/transversal-categories/uk-and-europe/nice-backs-celgenes-arthritis-pill/

But attendees warned to expect “oceanic” weather.

Janssen’s RA candidate among hot topics at EULAR

https://pharmaphorum.com/news/janssens-ra-candidate-among-hot-topics-eular/

arthritis